Zanubrutinib in Combination With Odronextamab for the Treatment of Patients With Richter's Transformation

Abroad (travel likely)RecruitingPHASE1

Conditions

Recurrent Transformed Chronic Lymphocytic Leukemia · Refractory Transformed Chronic Lymphocytic Leukemia · Richter Syndrome · Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • City of Hope Medical Center, Duarte, California, United States

    Contact: Study coordinator (Alexey V. Danilov) · adanilov@coh.org · 626-218-2405
    Contact: Principal Investigator (Alexey V. Danilov)
Study leads
  • Alexey V Danilov

    Principal Investigator

    City of Hope Medical Center